Novavax Statistics
NASDAQ: NVAXHealthcareBiotechnologyUSD
11.22-0.10 (-0.88%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Novavax by the numbers
Novavax has a market capitalization of $1.85 billion based on 164.95M shares outstanding. With trailing EPS of $-1.57, Novavax is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.0% above its 50-day average and 25.5% above its 200-day average.
Average daily trading volume is 5.11M shares, or about $57.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NVAX valuation vs. peer median
| Metric | NVAX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.85B | $1.71B | +8% |
| Avg. volume | 5.11M | 932.40K | +448% |
Peer median across 8 companies: TRVI, ADRX, URGN, AUPH, STOK, INVA, SNDX, IMCR.
Valuation
- Market cap
- $1.85B
- EPS (TTM)
- $-1.57
- Shares outstanding
- 164.95M
Price and trading
- Previous close
- 11.32
- Open
- 11.01
- Day range
- 10.90 – 11.75
- 52-week range
- 6.20 – 13.39
- 52-week change
- +21.69%
- Beta
- —
- Volume
- 8.36M
- Average volume
- 5.11M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.85B
- Forward Pe
- -18.28
- Eps
- -1.57
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.39
- Week52 Low
- 6.20
- Avg Volume
- 5.11M
- Shares Outstanding
- 164.95M
- Ma50
- 9.27
- Ma200
- 8.94
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -16.21%
- Pct From52w Low
- 80.97%